1Inan S,Kuscu NK,Vatansever S,et al. Increased vascular surface density in ovarian endometriosis. Gynecol Endocrinol,2003,17(2): 143-150.
2Ota H,Tanaka T. Stromal vascularizatoin in the endometriosis during adenomyosis. Microsc Res Tech, 2003,60 (4): 445-449.
3Goteri G,Lucarini G,Filosa A,et al. Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata. Fertil Steril,2004,81(6): 1528-1533.
4Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 1996,86(3):353-364.
5Matsuzaki S,Canis M,Vaurs-Barriere C,et al. DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection. Mol Hum Reprod,2004,10(10):719-728.
7Schindl M,Birner P,Obermair A,et al. Increased microvessel density in adenomyosis uteri. Ferti Steril,2001,75( 1):131-135.
8Khan KN,Masuzaki H,Fujishita A,et al. Immunoexpression of hepatocyte growth factor and c-Met receptor in the eutopic endometrium predicts the activity of ectopic endometrium. Fertil Steril, 2003,79( 1 ):173-181.
9Nisolle M, Casanas-Roux F, Donnez J. Early-stage endometriosis:adhesion and growth of human menstrual endometrium in nude mice. Fertil Steril,2000,74(2):306-312.
10Tan X J, Lang JH, Liu DY, et al. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril,2002,78(1):148-153.
二级参考文献18
1[1]Pepper MS. Manipulating angiogenesis. From basic science to the bedside[J]. Arterioscler Thromb Vasc Biol, 1997, 17(5): 605-19.
2[2]American society for Reproduction Medicine. Revised American society for reproduction medicine classification of endometriosis [J].Fetil Steril, 1997, 67(8): 817-21.
3[3]Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenasis[J]. Am J Pathol, 1995, 146(11): 1029-39.
4[4]Dhanabal M, Ramchandran R, Waterman MJ, et al. Endostatin induces endothelial cell apoptosis [J]. J Biol Chem, 1999, 274(17):11721-6.
5[6]Mclaren J. Vascular endothelial growth factor and endometriotic angiogenesis [ J ]. Hum Reprod Update, 2000, 6(1): 44-5.
6[7]Giudice LC, Tazuke SI, Swiersz LT. Status of current research on endometriosis[J]. J Reprod Med, 1998, 43(3 Suppl): 252-62.
7[9]Kupker W, Schultze-Mosgau A, Diedrich K. Paracrine changes in the peritoneal environment of women with endometriosis [J]. Hum Reprod Update, 1998, 4(5): 719-23.
8[10]Barcz E, Kaminski P, Marianowski L. VEGF concentration in peritoneal fluid of patients with endometriosis [ J ]. Ginekol Pol, 2001,72(5): 442-8.
9[12]Shaarawy M, E1-Sharkawy SA. Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer[J]. Acta Oncol, 2001, 40(4): 513-8.
10Aguayo A,Estey E,Kantarjian H,et al.Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia[J].Blood,1999,94: 3717-21.
